Determinants of Compliance With Glaucoma Therapy
This study is ongoing, but not recruiting participants.
Legacy Health System
Information provided by (Responsible Party):
Steven L. Mansberger, Legacy Health System
First received: November 30, 2011
Last updated: December 1, 2011
Last verified: November 2011
The purpose of this study is to determine which medical, demographic, and health belief factors are associated with glaucoma therapy compliance.
Open Angle Glaucoma
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Determinants of Compliance With Glaucoma Therapy|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Legacy Health System:
Primary Outcome Measures:
- Compliance with glaucoma medication at 1 month [ Time Frame: 1 month after enrollment ] [ Designated as safety issue: No ]Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.
- Compliance with glaucoma medication at 3 months [ Time Frame: 3 months after enrollment ] [ Designated as safety issue: No ]Compliance is measured using the Travatan Dosing Aid, a device that records when patients administer their topical glaucoma medication.
|Study Start Date:||August 2006|
|Estimated Study Completion Date:||December 2013|
|Estimated Primary Completion Date:||December 2013 (Final data collection date for primary outcome measure)|
Contacts and Locations